We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Prescription medicines under evaluation
Search applications for new medicines or new uses of existing medicines that are under our evaluation. This does not guarantee registration or Pharmaceutical Benefits Scheme (PBS) entry.
Application types:
- Application type A: applications for a 'new medicine' containing a new active substance (new chemical entity or new biological entity) not currently approved in Australia
- Application type B: applications for a 'new combination', where two or more already approved medicines are combined into a single product
- Application type C: applications for a 'new indication', or additional therapeutic use, for an already approved medicine.
For more information visit Prescription medicines: applications under evaluation.
Last updated
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Application type
Sponsor
- AstraZeneca Pty Ltd (7)
- Novartis Pharmaceuticals Australia Pty Ltd (7)
- Sanofi-Aventis Australia Pty Ltd (5)
- Bayer Australia Ltd (4)
- Eli Lilly Australia Pty Ltd (4)
- GlaxoSmithKline Australia Pty Ltd (4)
- Merck Sharp & Dohme (Australia) Pty Ltd (4)
- Accelagen Pty Ltd (3)
- Janssen-Cilag Pty Ltd (3)
- Specialised Therapeutics Alim Pty Ltd (3)
- Takeda Pharmaceuticals Australia Pty Ltd (3)
- AbbVie Pty Ltd (2)
- Chiesi Australia Pty Ltd (2)
- Dr Falk Pharma Australia Pty Ltd (2)
- Dr Reddys Laboratories Australia Pty Ltd (2)
- Fresenius Medical Care Australia Pty Ltd (2)
- Gilead Sciences Pty Ltd (2)
- Moderna Australia Pty Ltd (2)
- Novo Nordisk Pharmaceuticals Pty Ltd (2)
- ORGANON PHARMA PTY LTD (2)
- Pierre Fabre Australia Pty Ltd (2)
- Seqirus Pty Ltd (2)
- Servier Laboratories (Aust) Pty Ltd (2)
- Swedish Orphan Biovitrum Pty Ltd (2)
- AA-Med Pty Ltd (1)
- Acumen Dental Unit Trust (1)
- AFT Pharmaceuticals Pty Ltd (1)
- Alexion Pharmaceuticals Australasia Pty Ltd (1)
- Amivas Australia Pty Ltd (1)
- Anthia Life Sciences Pty Ltd (1)
- Argenx Australia Pty Ltd (1)
- Arrowhead Australia Pty Ltd (1)
- BeOne Medicines AUS Pty Ltd (1)
- Besins Healthcare Australia Pty Ltd (1)
- Biogen Australia Pty Ltd (1)
- Bristol-Myers Squibb Australia Pty Ltd (1)
- Celltrion Healthcare Australia Pty Ltd (1)
- Cipla Australia Pty Ltd (1)
- CSL Behring (Australia) Pty Ltd (1)
- Freyr Australia Pty Ltd (1)
- Indivior Pty Ltd (1)
- Innocare Pharma Australia Pty Ltd (1)
- iNova Pharmaceuticals (Australia) Pty Ltd (1)
- Ipsen Pty Ltd (1)
- Kyowa Kirin Australia Pty Ltd (1)
- Mayne Pharma International Pty Ltd (1)
- Medison Pharma Australia Pty Ltd (1)
- MS Health Pty Ltd (1)
- Norgine Pty Ltd (1)
- Orion Pharma (AUS) Pty Limited (1)
- Otsuka Australia Pharmaceutical Pty Ltd (1)
- RAD Data Australia Pty Ltd (1)
- Reach Pharmaceuticals Pty Ltd (1)
- Roche Products Pty Ltd (1)
- Specialised Therapeutics Pharma Pty Ltd (1)
- Teva Pharma Australia Pty Ltd (1)
- Viatris Pty Ltd (1)
Search
106 result(s) found, displaying 101 to 106
-
-
Sep-2024Prescription medicine evaluationActive ingredient: lidocaine hydrochloride.
-
Sep-2024Prescription medicine evaluationActive ingredient: ropinirole hydrochloride.
-
Sep-2024Prescription medicine evaluationActive ingredient: Liraglutide.
-
Aug-2024Prescription medicine evaluationActive ingredient: Artesunate.
-
Jan-2024Prescription medicine evaluationActive ingredient: sodium citrate dihydrate.
Last updated